|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 33/24 | |
| A61P 19/10 |
| (11) | Number of the document | 1294384 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01940848.3 |
| Date of filing the European patent application | 2001-06-26 | |
| (97) | Date of publication of the European application | 2003-03-26 |
| (45) | Date of publication and mention of the grant of the patent | 2009-03-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2001/002836 |
| Date | 2001-06-26 |
| (87) | Number | WO 2002/000227 |
| Date | 2002-01-03 |
| (30) | Number | Date | Country code |
| 0015745 | 2000-06-27 | GB |
| (72) |
ATHERTON, Nigel Derek Shire Pharmac. Group PLC, GB
TOTTEN, Joseph W, Shire Pharmaceuticals Group PLC, GB
GAITONDE, Michael, David, CH
|
| (73) |
Shire Holdings AG,
Bundersstrasse 5, 6300 Zug,
CH
|
| (54) | USE OF LANTHANUM COMPOUNDS FOR THE TREATMENT OF BONE DISEASES |
| USE OF LANTHANUM COMPOUNDS FOR THE TREATMENT OF BONE DISEASES |